NASDAQ:DRUG - Nasdaq - CA10919W4056 - Common Stock - Currency: USD
MRQ (2024-6-30) | 2022 (2022-9-30) | 2021 (2021-9-30) | 2020 (2020-9-30) | 2019 (2019-9-30) | ||||
---|---|---|---|---|---|---|---|---|
ASSETS | ||||||||
Current Assets | ||||||||
Cash | N/A | N/A | 19.76M | 799.93K | 79.99K | |||
Cash Equivalents | 6.19M | N/A | N/A | N/A | N/A | |||
Receivables | 17.24K | N/A | 110.15K | N/A | N/A | |||
Other Current Assets | 58.32K | N/A | 168.21K | 78.29K | 0.00 | |||
Total Current Assets | 6.27M | N/A | 20.04M | 878.22K | 79.99K | |||
Non-Current Assets | ||||||||
PPE Net | 12.08K | N/A | N/A | N/A | N/A | |||
Intangibles | N/A | N/A | 2.00K | 2.00K | 2.00K | |||
Total Non-Current Assets | 12.07K | N/A | 2.00K | 2.00K | 2.00K | |||
TOTAL ASSETS | 6.28M | N/A | 20.04M | 880.22K | 81.99K | |||
LIABILITIES | ||||||||
Current Liabilities | ||||||||
Short Term Debt | 0.00 | N/A | 0.00 | 0.00 | 0.00 | |||
Current Portion Of LT Debt. | 14.02K | N/A | N/A | N/A | N/A | |||
Accrued Expenses | 15.00K | N/A | 42.00K | 12.50K | 0.00 | |||
Accounts Payable | 149.61K | N/A | 596.57K | 138.42K | 36.71K | |||
Total Current Liabilities | 178.63K | N/A | 638.57K | 150.92K | 36.71K | |||
Non-Current Liabilities | ||||||||
Long Term Debt | 0.00 | N/A | 0.00 | 0.00 | 0.00 | |||
Total Non-Current Liabilities | 0.00 | N/A | 0.00 | 0.00 | 0.00 | |||
TOTAL LIABILITIES | 178.63K | N/A | 638.57K | 150.92K | 36.71K | |||
SHAREHOLDERS' EQUITY | ||||||||
Retained Earnings | -28.95M | N/A | -7.64M | -397.79K | -78.72K | |||
Common Shares | 35.05M | N/A | 27.08M | 980.66K | 205.98K | |||
Other Shareholders' Equity | N/A | N/A | -33.68K | 146.43K | -81.98K | |||
Shares Outstanding | 4.46M | N/A | 2.37M | 1.28M | 1.28M | |||
Tangible Book Value per Share | 1.37 | N/A | 8.20 | 0.57 | 0.03 | |||
Total Shareholders' Equity | 6.10M | N/A | 19.40M | 729.29K | 45.28K | |||
TOTAL LIABILITIES AND EQUITY | 6.28M | N/A | 20.04M | 880.22K | 81.99K | |||
Statistics | ||||||||
Current Ratio | 35.08 | N/A | 31.38 | 5.82 | 2.18 | |||
Return On Assets (ROA) | -56.65% | N/A | -43.17% | -54.57% | -96.01% | |||
Return On Equity (ROE) | -58.31% | N/A | -44.59% | -65.87% | -173.85% |
All data in CAD , ROIC based on taxRate of 0.21